Fainting rarely announces itself, which is why falls caused by vasovagal syncope send hundreds of thousands of people to emergency rooms every year with head injuries and fractures. A study published in the European Heart Journal – Digital Health, conducted jointly by Samsung and Chung-Ang University Gwangmyeong Hospital in South Korea, found that an AI algorithm running on a Galaxy Watch’s existing sensor can predict an impending fainting episode up to five minutes before it happens, with 84.6% accuracy and 90% sensitivity.
How the Watch Sees It Coming
The system relies on photoplethysmography, the same green-light sensor already built into most consumer smartwatches to measure heart rate, but instead of just counting beats, the AI model analyzes subtle patterns in heart rate variability that precede a vasovagal episode, according to Samsung’s newsroom release. Vasovagal syncope occurs when the nervous system overreacts to a trigger, such as standing too long, extreme emotion or pain, causing heart rate and blood pressure to plunge suddenly and starving the brain of blood flow. Those physiological shifts, it turns out, leave a detectable fingerprint in heart rate variability data minutes before a person actually loses consciousness.
Inside the Clinical Trial
Researchers enrolled 132 patients with suspected vasovagal syncope and put them through a tilt-table test, a standard diagnostic procedure in which patients are strapped to a table that is tilted upright to medically provoke a fainting episode under controlled, monitored conditions, according to the peer-reviewed study. Throughout the test, participants wore a Galaxy Watch, and the AI model was trained to recognize the heart rate variability patterns that showed up in the minutes before each induced faint. The resulting 84.6% predictive accuracy and 90% sensitivity mean the system correctly flagged the large majority of true fainting events, an important benchmark for any tool meant to trigger a real-world warning.
What Five Minutes of Warning Actually Buys You
Clinicians involved in the research argue the clinical value isn’t in preventing the faint itself but in preventing the injury that follows it. An early alert gives a person time to sit or lie down, move away from stairs or traffic, or notify a caregiver, converting an unpredictable collapse into a managed event, researchers said. For older adults and people with recurrent syncope, secondary injuries from uncontrolled falls, including hip fractures and head trauma, are often more dangerous than the fainting spell itself.
Consumer Sensors Doing Clinical-Grade Work
The result adds to a growing body of evidence that off-the-shelf wearable sensors, originally built for fitness tracking, can be repurposed for genuine early-warning medical applications when paired with the right AI model. Samsung has increasingly positioned its Galaxy Watch line as a health-research platform rather than purely a consumer gadget, following similar efforts by competitors to validate arrhythmia and blood-oxygen detection features through peer-reviewed studies rather than marketing claims alone.
Caveats Before It Reaches Your Wrist
The study’s authors and outside cardiologists caution that a 132-patient tilt-table trial, while methodologically rigorous, is still a controlled clinical setting rather than everyday life, where confounders like exercise, caffeine, dehydration and emotional stress could complicate the heart rate variability signal the AI is trained to catch. Sensitivity of 90% also means one in ten true fainting events could still be missed, and the specificity of the system, meaning how often it correctly identifies when someone will not faint, has drawn less public attention so far. Wider, real-world validation across more diverse patient populations, including different ages, medications and comorbidities, will be needed before regulators or physicians treat the feature as a clinical-grade warning system rather than a promising research finding.
What’s Next
Samsung has not announced a commercial rollout timeline for the fainting-prediction feature, and any such feature would likely require its own regulatory clearance path distinct from the watch’s existing heart-rhythm features. If it does reach consumer devices, it would mark one of the first times a mainstream wearable moved from measuring a health metric to actively forecasting a specific, imminent medical event, a shift that could reshape how millions of smartwatch wearers with fainting histories manage their daily risk.
Photo: Asotac / PIXABAY via Pixabay
